Cargando…

The intron-enriched HERV-K(HML-10) family suppresses apoptosis, an indicator of malignant transformation

BACKGROUND: Human endogenous retroviruses (HERVs) constitute 8% of the human genome and contribute substantially to the transcriptome. HERVs have been shown to generate RNAs that modulate host gene expression. However, experimental evidence for an impact of these regulatory transcripts on the cellul...

Descripción completa

Detalles Bibliográficos
Autores principales: Broecker, Felix, Horton, Roger, Heinrich, Jochen, Franz, Alexandra, Schweiger, Michal-Ruth, Lehrach, Hans, Moelling, Karin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5142424/
https://www.ncbi.nlm.nih.gov/pubmed/27980690
http://dx.doi.org/10.1186/s13100-016-0081-9
_version_ 1782472773829918720
author Broecker, Felix
Horton, Roger
Heinrich, Jochen
Franz, Alexandra
Schweiger, Michal-Ruth
Lehrach, Hans
Moelling, Karin
author_facet Broecker, Felix
Horton, Roger
Heinrich, Jochen
Franz, Alexandra
Schweiger, Michal-Ruth
Lehrach, Hans
Moelling, Karin
author_sort Broecker, Felix
collection PubMed
description BACKGROUND: Human endogenous retroviruses (HERVs) constitute 8% of the human genome and contribute substantially to the transcriptome. HERVs have been shown to generate RNAs that modulate host gene expression. However, experimental evidence for an impact of these regulatory transcripts on the cellular phenotype has been lacking. RESULTS: We characterized the previously little described HERV-K(HML-10) endogenous retrovirus family on a genome-wide scale. HML-10 invaded the ancestral genome of Old World monkeys about 35 Million years ago and is enriched within introns of human genes when compared to other HERV families. We show that long terminal repeats (LTRs) of HML-10 exhibit variable promoter activity in human cancer cell lines. One identified HML-10 LTR-primed RNA was in opposite orientation to the pro-apoptotic Death-associated protein 3 (DAP3). In HeLa cells, experimental inactivation of HML-10 LTR-primed transcripts induced DAP3 expression levels, which led to apoptosis. CONCLUSIONS: Its enrichment within introns suggests that HML-10 may have been evolutionary co-opted for gene regulation more than other HERV families. We demonstrated such a regulatory activity for an HML-10 RNA that suppressed DAP3-mediated apoptosis in HeLa cells. Since HML-10 RNA appears to be upregulated in various tumor cell lines and primary tumor samples, it may contribute to evasion of apoptosis in malignant cells. However, the overall weak expression of HML-10 transcripts described here raises the question whether our result described for HeLa represent a rare event in cancer. A possible function in other cells or tissues requires further investigation. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13100-016-0081-9) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5142424
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-51424242016-12-15 The intron-enriched HERV-K(HML-10) family suppresses apoptosis, an indicator of malignant transformation Broecker, Felix Horton, Roger Heinrich, Jochen Franz, Alexandra Schweiger, Michal-Ruth Lehrach, Hans Moelling, Karin Mob DNA Research BACKGROUND: Human endogenous retroviruses (HERVs) constitute 8% of the human genome and contribute substantially to the transcriptome. HERVs have been shown to generate RNAs that modulate host gene expression. However, experimental evidence for an impact of these regulatory transcripts on the cellular phenotype has been lacking. RESULTS: We characterized the previously little described HERV-K(HML-10) endogenous retrovirus family on a genome-wide scale. HML-10 invaded the ancestral genome of Old World monkeys about 35 Million years ago and is enriched within introns of human genes when compared to other HERV families. We show that long terminal repeats (LTRs) of HML-10 exhibit variable promoter activity in human cancer cell lines. One identified HML-10 LTR-primed RNA was in opposite orientation to the pro-apoptotic Death-associated protein 3 (DAP3). In HeLa cells, experimental inactivation of HML-10 LTR-primed transcripts induced DAP3 expression levels, which led to apoptosis. CONCLUSIONS: Its enrichment within introns suggests that HML-10 may have been evolutionary co-opted for gene regulation more than other HERV families. We demonstrated such a regulatory activity for an HML-10 RNA that suppressed DAP3-mediated apoptosis in HeLa cells. Since HML-10 RNA appears to be upregulated in various tumor cell lines and primary tumor samples, it may contribute to evasion of apoptosis in malignant cells. However, the overall weak expression of HML-10 transcripts described here raises the question whether our result described for HeLa represent a rare event in cancer. A possible function in other cells or tissues requires further investigation. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13100-016-0081-9) contains supplementary material, which is available to authorized users. BioMed Central 2016-12-07 /pmc/articles/PMC5142424/ /pubmed/27980690 http://dx.doi.org/10.1186/s13100-016-0081-9 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Broecker, Felix
Horton, Roger
Heinrich, Jochen
Franz, Alexandra
Schweiger, Michal-Ruth
Lehrach, Hans
Moelling, Karin
The intron-enriched HERV-K(HML-10) family suppresses apoptosis, an indicator of malignant transformation
title The intron-enriched HERV-K(HML-10) family suppresses apoptosis, an indicator of malignant transformation
title_full The intron-enriched HERV-K(HML-10) family suppresses apoptosis, an indicator of malignant transformation
title_fullStr The intron-enriched HERV-K(HML-10) family suppresses apoptosis, an indicator of malignant transformation
title_full_unstemmed The intron-enriched HERV-K(HML-10) family suppresses apoptosis, an indicator of malignant transformation
title_short The intron-enriched HERV-K(HML-10) family suppresses apoptosis, an indicator of malignant transformation
title_sort intron-enriched herv-k(hml-10) family suppresses apoptosis, an indicator of malignant transformation
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5142424/
https://www.ncbi.nlm.nih.gov/pubmed/27980690
http://dx.doi.org/10.1186/s13100-016-0081-9
work_keys_str_mv AT broeckerfelix theintronenrichedhervkhml10familysuppressesapoptosisanindicatorofmalignanttransformation
AT hortonroger theintronenrichedhervkhml10familysuppressesapoptosisanindicatorofmalignanttransformation
AT heinrichjochen theintronenrichedhervkhml10familysuppressesapoptosisanindicatorofmalignanttransformation
AT franzalexandra theintronenrichedhervkhml10familysuppressesapoptosisanindicatorofmalignanttransformation
AT schweigermichalruth theintronenrichedhervkhml10familysuppressesapoptosisanindicatorofmalignanttransformation
AT lehrachhans theintronenrichedhervkhml10familysuppressesapoptosisanindicatorofmalignanttransformation
AT moellingkarin theintronenrichedhervkhml10familysuppressesapoptosisanindicatorofmalignanttransformation
AT broeckerfelix intronenrichedhervkhml10familysuppressesapoptosisanindicatorofmalignanttransformation
AT hortonroger intronenrichedhervkhml10familysuppressesapoptosisanindicatorofmalignanttransformation
AT heinrichjochen intronenrichedhervkhml10familysuppressesapoptosisanindicatorofmalignanttransformation
AT franzalexandra intronenrichedhervkhml10familysuppressesapoptosisanindicatorofmalignanttransformation
AT schweigermichalruth intronenrichedhervkhml10familysuppressesapoptosisanindicatorofmalignanttransformation
AT lehrachhans intronenrichedhervkhml10familysuppressesapoptosisanindicatorofmalignanttransformation
AT moellingkarin intronenrichedhervkhml10familysuppressesapoptosisanindicatorofmalignanttransformation